Metavasi Capital’s Hims & Hers Health HIMS Stock Holding History

Metavasi Capital’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.61M	Buy	+222,000	New	+$5.24M	1.67%	18
2025 Q4	–	Sell	-166,409	Closed	-$9.44M	–	31
2025 Q3	$9.44M	Sell	166,409 -20,000	-11%	-$1.02M	2.85%	14
2025 Q2	$9.29M	Sell	186,409 -7,559	-4%	-$342K	3.79%	9
2025 Q1	$5.73M	Buy	193,968 +6,545	+3%	+$243K	3.64%	9
2024 Q4	$4.53M	Sell	187,423 -247,000	-57%	-$6.12M	1.6%	20
2024 Q3	$8M	Sell	434,423 -70,577	-14%	-$1.26M	3.64%	12
2024 Q2	$10.2M	Buy	+505,000	New	+$8.4M	5.35%	3
2023 Q3	–	Sell	-560,000	Closed	-$5.26M	–	34
2023 Q2	$5.26M	Buy	+560,000	New	+$5.55M	3.43%	12

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Defiance ETFs New York $6.98B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Metavasi Capital's HIMS Position: Q1 2026 in Review

Metavasi Capital opened a new position in Hims & Hers Health (HIMS) in Q1 2026: 222,000 shares worth $4.61M. The stake represents 1.67% of the portfolio and ranks #18 among its holdings. This is a return to the name: Metavasi Capital previously reported a position in HIMS as recently as Q3 2025.

Metavasi Capital first reported a position in HIMS in Q2 2023 and has held it in 8 quarters since. The position peaked at $10.2M in Q2 2024. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

Metavasi Capital held 222,000 shares of Hims & Hers Health worth $4.61M as of Q1 2026.
Hims & Hers Health was a new Metavasi Capital position in Q1 2026.
Hims & Hers Health made up 1.67% of Metavasi Capital's portfolio in Q1 2026, its #18 holding.
Metavasi Capital first reported a position in Hims & Hers Health in Q2 2023 and has held it in 8 quarters since.
Metavasi Capital's Hims & Hers Health position peaked at $10.2M in Q2 2024.
434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Metavasi Capital's 13F filing for Q1 2026, filed 15 May 2026.